Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.
A new study by Peking University researchers links smoking to an increased risk of developing chronic kidney disease, particularly in its advanced stages. The study, published in Health Data Science ...